Literature DB >> 9270672

Clinical features of perineuritis.

E J Sorenson1, A A Sima, M Blaivas, K Sawchuk, J J Wald.   

Abstract

We report 13 patients with pathologically confirmed perineuritis. Seven patients had diabetes mellitus, 5 had nutritional abnormalities, 2 had associated rheumatological illnesses, 2 had sepsis with multiorgan failure, and 1 had a history of malignancy. Electrophysiologic testing demonstrated mononeuritis multiplex in 7, demyelinating neuropathy in 4, distal sensory and motor neuropathy in 1, and polyradiculoneuropathy in 1. Twelve patients received immunomodulating therapy with variable responses. We conclude that perineuritis is associated with a number of different systemic conditions and several clinical patterns of peripheral neuropathy. Response to immunomodulation is variable. The most frequent association is with diabetes mellitus, a previously unrecognized association.

Entities:  

Mesh:

Year:  1997        PMID: 9270672     DOI: 10.1002/(sici)1097-4598(199709)20:9<1153::aid-mus10>3.0.co;2-u

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Long lasting recruitment of immune cells and altered epi-perineurial thickness in focal nerve inflammation induced by complete Freund's adjuvant.

Authors:  Geoffrey M Bove; Wendy Weissner; Mary F Barbe
Journal:  J Neuroimmunol       Date:  2009-06-28       Impact factor: 3.478

2.  Neuromuscular Mimics of Entrapment Neuropathies of Upper Extremities.

Authors:  James M Gilchrist; Sudeepta Dandapat
Journal:  Hand (N Y)       Date:  2020-02-05

3.  Nerve biopsy findings contribute to diagnosis of multiple mononeuropathy: 78% of findings support clinical diagnosis.

Authors:  Ying-Shuang Zhang; A-Ping Sun; Lu Chen; Rong-Fang Dong; Yan-Feng Zhong; Jun Zhang
Journal:  Neural Regen Res       Date:  2015-01       Impact factor: 5.135

4.  Perineuritis Successfully Treated with Early Aggressive Immunotherapy.

Authors:  Takumi Nakamura; Takeshi Kawarabayashi; Yusuke Seino; Mie Hirohata; Koichi Wakabayashi; Mikio Shoji
Journal:  Intern Med       Date:  2019-06-27       Impact factor: 1.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.